You are currently on the new version of our website. Access the old version .

Most Recent

  • Article
  • Open Access

Targeted Removal of HCV E2 N2 N-Glycan Is Associated with Improved Immune Responses in Mice

  • Yuan-Qin Min,
  • Yu-Shan Ren,
  • Wen-Wen Zhang,
  • Yi-Dan Zhou and
  • Min Liu
Biomolecules2026, 16(2), 183;https://doi.org/10.3390/biom16020183 
(registering DOI)

24 January 2026

Hepatitis C virus (HCV) still lacks a licensed vaccine. The envelope glycoprotein E2 is a key neutralizing target, but its dense N-glycan shield can hinder epitope exposure. In this study, we revisit E2 glycan editing and examine whether single-site...

  • Article
  • Open Access

Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid

  • Shirin Emtenani,
  • Tina Rastegar Lari,
  • Charlotte Kiehne,
  • Nina van Beek,
  • Maike M. Holtsche and
  • Enno Schmidt

23 January 2026

Anti-p200 pemphigoid is an autoimmune blistering disease (AIBD) caused by autoantibodies against laminin β4 and/or γ1, and clinically resembles bullous pemphigoid (BP) as well as the inflammatory variant of epidermolysis bullosa acquisita...

  • Article
  • Open Access

TRIC-A Loss Sensitizes the Heart to β-Adrenergic Stress and Drives Cardiomyocyte Death and Fibrosis

  • Ki Ho Park,
  • Daiju Yamazaki,
  • Xinyu Zhou,
  • Shinji Komazaki,
  • Chengzhu Zhao,
  • Miyuki Nishi,
  • Jingsong Zhou,
  • Hiroshi Takeshima and
  • Jianjie Ma

23 January 2026

Trimeric intracellular cation channel A (TRIC-A) provides counter-ion support for sarcoplasmic reticulum (SR) Ca2+ release, yet its physiological role in the intact heart under stress remains poorly defined. Here, we demonstrate that TRIC-A is essent...

  • Article
  • Open Access

TrkB Agonist Treatment Decreases Hippocampal Testosterone Contents in a Sex-Dependent Manner Following Neonatal Hypoxia and Ischemia

  • Nur Aycan,
  • Irem Isik,
  • Nur Sena Cagatay,
  • Feyza Cetin,
  • Teresita J. Valdes-Arciniega,
  • Burak Ozaydin,
  • Sefer Yapici,
  • Robinson W. Goy,
  • Luc Collo and
  • Pelin Cengiz
  • + 5 authors

23 January 2026

Hypoxia–ischemia (HI)-related brain injury impacts millions of neonates worldwide. Male neonates are two times more susceptible to developing HI. We have previously reported that the administration of the neurotrophin receptor tyrosine kinase B...

  • Article
  • Open Access

2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents

  • Giovanna Lucia Delogu,
  • Michela Begala,
  • Manuel Novás,
  • Maria João Matos,
  • Franca Piras,
  • Sonia Floris,
  • Francesca Pintus,
  • Michele Mancinelli,
  • Benedetta Era and
  • Antonella Fais

22 January 2026

New arylbenzofuran derivatives were designed, synthesized, and evaluated as potential inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Five hybrid compounds (31–35) feature a 2-phenylbenzofuran core linked via a hepty...

  • Review
  • Open Access

Novel Insights into TSC22D Family Genes in Metabolic Diseases and Cancer

  • Wen Shen,
  • Cong Shen,
  • Yang Jiao,
  • Xia Deng,
  • Jue Jia and
  • Guoyue Yuan

22 January 2026

Transforming growth factor-beta 1 (TGF-β1)-stimulated clone 22 domain (TSC22D) family genes (including TSC22D1-TSC22D4) were identified as transcription factors. It has been demonstrated that they display multiple functions due to proteins&rsquo...

  • Article
  • Open Access

Biological Evaluation and SAR Exploration of Bile Acid–Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer

  • Daniela Perrone,
  • Elisabetta Melloni,
  • Lorenzo Gnudi,
  • Fabio Casciano,
  • Elena Pozza,
  • Francesca Bompan,
  • Paola Secchiero,
  • Elena Marchesi and
  • Maria Luisa Navacchia

22 January 2026

Dihydroartemisinin (DHA), a first-line treatment for uncomplicated malaria, has demonstrated antitumor activity against a variety of human cancers, emphasizing its potential for repurposing as an anticancer agent. However, its short half-life and poo...

  • Article
  • Open Access
58 Views
21 Pages

Design and Physicochemical Characterization of Hybrid PLGA–Curcumin/Carbon Dot Nanoparticles for Sustained Galantamine Release: A Proof-of-Concept Study

  • Christina Samiotaki,
  • Stavroula Nanaki,
  • Rizos Evangelos Bikiaris,
  • Evi Christodoulou,
  • George Z. Kyzas,
  • Panagiotis Barmpalexis and
  • Dimitrios N. Bikiaris

21 January 2026

The present study reports the design and physicochemical characterization of a hybrid nanoparticle system for the potential intranasal delivery of galantamine (GAL), aimed at improving its bioavailability. Carbon dots (CDs) were used to load GAL, enh...

  • Article
  • Open Access
146 Views
19 Pages

Cyclic-FMN Is a Detectable, Putative Intermediate of FAD Metabolism

  • Luxene Belfleur,
  • Juha P. Kallio,
  • Wito Richter,
  • Natalie R. Gassman,
  • Mathias Ziegler and
  • Marie E. Migaud

21 January 2026

Free flavin adenine dinucleotide (FAD) is metabolized to flavin mononucleotide (FMN) and adenine monophosphate (AMP) by hydrolases and to 4′,5′-cyclic phosphoriboflavin (cFMN) and AMP by the triose kinase FMN cyclase (TKFC). Yet, the lack...

  • Review
  • Open Access
287 Views
45 Pages

A Comprehensive Review of Epigenetic Regulation of Vascular Smooth Muscle Cells During Development and Disease

  • Lautaro Natali,
  • Benjamín de la Cruz-Thea,
  • Andrea Godino,
  • Cecilia Conde,
  • Victor I. Peinado and
  • Melina M. Musri

21 January 2026

Vascular smooth muscle cells (VSMCs) in the tunica media are essential for maintaining the structure and function of the arterial wall. These cells regulate vascular tone and contribute to vasculogenesis and angiogenesis, particularly during developm...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomolecules - ISSN 2218-273X